Previous close | 26.73 |
Open | 26.94 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 26.94 - 26.94 |
52-week range | 18.65 - 30.30 |
Volume | |
Avg. volume | 1,000 |
Market cap | 54.332B |
Beta (5Y monthly) | 1.07 |
PE ratio (TTM) | 11.61 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.70 (2.61%) |
Ex-dividend date | 28 Mar 2024 |
1y target est | N/A |
Assar Gabrielsson was one of the founders of Volvo. In accordance with his wishes, a fund was established for clinical research of cancer diseases. The fund has existed since 1962. It primarily supports research projects that are considered promising but have not yet reached the weight that provides funding from major research funds.
The number of votes in AB Volvo has changed due to the conversion of a total of 100 Series A shares to a total of 100 Series B shares. The conversions were implemented with the support of the opportunity for Series A shareholders to request conversion of Series A shares to Series B shares which was entered in the Articles of Association at the 2011 Annual General Meeting.
"During Q1 2024, demand continued to normalize at good levels across many of the Volvo Group's markets. Adjusted for currency, net sales were on the same level as in Q1 2023 and amounted to SEK 131.2 billion. Invoiced price continued to increase, mainly on the back of carry-over from the price increases we gradually implemented last year. Adjusted operating income amounted to SEK 18.2 billion (18.6), which corresponds to a margin of 13.8% (14.0). Return on capital employed improved to 37.7% (30.